{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-356168","form_type":"8-K","ticker":"MREO","cik":"0001719714","company_name":"Mereo BioPharma Group plc","filed_at":"2026-08-19T11:52:29+00:00","discovered_at":"2026-08-19T11:55:16.087562+00:00","generated_at":"2026-08-19T11:55:20.040234+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Mereo BioPharma gets second Nasdaq notice; extra 180 days to meet $1 bid price","bullets":["Received second Nasdaq notice on Aug 18, 2026; new compliance deadline Feb 16, 2027.","Must close at $1.00+ for 10 consecutive business days to regain compliance.","If not compliant by Feb 16, 2027, Nasdaq will issue delisting notice; company may appeal.","First notice received Feb 17, 2026; initial 180-day period expired Aug 17, 2026.","Company monitoring bid price and considering options to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-356168","json":"https://secwatch.observer/filing/0001193125-26-356168.json","markdown":"https://secwatch.observer/filing/0001193125-26-356168.md","text":"https://secwatch.observer/filing/0001193125-26-356168.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526356168/0001193125-26-356168-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526356168/mreo-20260217.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-19T11:55:20.040234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}